YCBD vs PHIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 25, 2026

YCBD

48.5
AI Score
VS
PHIO Wins

PHIO

61.1
AI Score

Investment Advisor Scores

YCBD

49score
Recommendation
HOLD

PHIO

61score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric YCBD PHIO Winner
Net Income -2.21M -6.33M YCBD
Operating Income -2.22M -6.33M YCBD
ROE -26.9% -41.0% YCBD
ROA -16.8% -34.7% YCBD
Total Assets 13.15M 18.24M PHIO
Cash 2.12M 16.87M PHIO
Current Ratio 2.50 7.90 PHIO
Free Cash Flow -2.17M -6.20M YCBD

Relative Price Performance (Last 90 Days)

YCBD 1M: -8.8% · 3M: -36.0% PHIO 1M: -12.8% · 3M: -0.5%

Current Technical Phase

YCBD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -13.8%), weak momentum, RSI 44

RSI (14): 44.2 · Price: $0.46

PHIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 39

RSI (14): 39.0 · Price: $0.99

Fundamentals Snapshot

Metric YCBD PHIO
Market Cap — —
Forward P/E -2.4 -1.6
Trailing P/E 2.0 —
Revenue (TTM) — —
Revenue Growth 0.2% 0.0%
Gross Margin 0.6% —
Operating Margin -0.2% 0.0%
EPS 0.23 -1.29
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, PHIO is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.